Drug Shortage Report for TWYNSTA
Report ID | 49695 |
Drug Identification Number | 02371022 |
Brand name | TWYNSTA |
Common or Proper name | TWYNSTA 40 + 5 MG |
Company Name | BOEHRINGER INGELHEIM (CANADA) LTD LTEE |
Market Status | MARKETED |
Active Ingredient(s) | AMLODIPINE TELMISARTAN |
Strength(s) | 5MG 40MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 4 x 7 |
ATC code | C09DB |
ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2018-05-17 |
Estimated end date | 2018-06-22 |
Actual end date | 2018-05-29 |
Shortage status | Resolved |
Updated date | 2018-05-30 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 5180 SOUTH SERVICE ROAD BURLINGTON, ONTARIO CANADA L7L 5H4 |
Company contact information | 1800 263 2425 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2018-05-30 | English | Compare |
v4 | 2018-05-29 | French | Compare |
v3 | 2018-05-29 | English | Compare |
v2 | 2018-05-18 | French | Compare |
v1 | 2018-05-18 | English | Compare |
Showing 1 to 5 of 5